Cream Cheese Recall Upgraded Over Listeria Risk, FDA Says
via HealthDayTUESDAY, March 17, 2026 — Health officials are warning consumers about a cream cheese recall that has been raised to the most critical level due to possible bacterial contamination.
The U.S. Food and Drug Administration (FDA) said certain cream cheese products made by Made Fresh Salads Inc. may contain Listeria monocytogenes, a bacteria that can cause severe illness.
The company first announced the recall Feb. 20, after routine testing found contamination linked to equipment.
On March 11, the FDA upgraded the alert to a Class I recall, which means there is "a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death."
The affected products were sold in 5-pound white plastic tubs with a Made Fresh Salads label. They were distributed to stores and food providers in Brooklyn, Queens, the Bronx and other parts of New York City.
The recalled products have expiration dates through Feb. 27.
Flavors include:
The FDA said the issue was traced to “a part of the mixer used to manufacture finished products” that tested positive for listeria.
The company has stopped using that equipment and removed it from service.
So far, no illnesses have been linked to the recalled cream cheeses.
Still, health officials say listeria infections can be serious, especially for kids and older folks.
Symptoms can include fever, headache, stomach ache and diarrhea, the FDA said.
Consumers who bought the recalled cream cheese should return it to the store where it was purchased for a refund.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-18 02:00
Read more
- Poor Childhood Oral Health Linked to Atherosclerotic CVD in Adulthood
- Health Care Costs Impacting Families' Financial Decisions
- U.S. FDA Approves Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis
- Study Finds 'Forever Chemicals' on California Fruits and Vegetables
- Mammograms May Also Reveal Hidden Heart Disease Risk, Study Finds
- Laser Red-Light Therapy Delivers Irradiance Levels Exceeding Safety Limits
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions